NewsTrending topic
The "Hybrid Orthomolecular Protocol" Instagram Nurses Are Promoting for Cancer: What's Behind It
An Instagram post promotes Dr. Ilyes Baghli's Hybrid Orthomolecular Protocol for cancer, which pairs ivermectin with vitamins and fasting. Here is who published it, who co-authored it, and what the evidence shows.
Original commentary from the Cancer Explained editorial team.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
An Instagram post from a nurse-influencer encourages people to look into ivermectin for cancer. It names Dr. Ilyes Baghli's "Hybrid Orthomolecular Protocol for Cancer." The post presents it as an evidence-based option that patients should know about. We've checked the broader claim that ivermectin treats cancer elsewhere twice before. This post names something more specific. It is a named plan, with a named author. So we looked at it directly.
What's real
Dr. Ilyes Baghli is a doctor from Algiers, Algeria. News reports say he became head of the International Society for Orthomolecular Medicine (ISOM). The plan the post refers to is a real, published paper. Its title is "Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol." It ran in the Journal of Orthomolecular Medicine in 2024.
The paper puts forward a theory. It says some cancer cells start when the cell's power plants, called mitochondria, stop making energy well. To fix that, it suggests a mix of things. These include high doses of vitamins and minerals, and older drugs used in new ways, such as ivermectin and mebendazole. It also suggests a very low-carb (keto) diet with periods of water-only fasting, and exercise or oxygen treatment in a pressure chamber.
So the plan is real in one sense. It exists, a licensed doctor wrote it, and it was published. That's more than most viral "hidden cure" claims can say.
What's missing
The post leaves out some things that matter a lot if you're deciding whether to trust this.
The Journal of Orthomolecular Medicine is not listed in MEDLINE. That is the National Library of Medicine's list of journals that meet its bar for quality. That doesn't make everything in it wrong. But it means cancer experts have not checked the plan the way cancer journals require. That kind of review comes before cancer doctors take a treatment idea seriously.
One of the paper's co-authors is Dr. William Makis, a Canadian radiologist. Alberta's College of Physicians and Surgeons says he has not held an active medical license since February 2019. In March 2026, an Alberta court issued a permanent order against him. It bars him from calling himself a doctor or implying he is licensed. It also bars him from offering health services to the public in Alberta.
The fact-check group Science Feedback reviewed this exact paper. It rated the paper's claims "unsupported." It found the plan relies on lab and animal studies, single case reports, and studies that were not built to test whether ivermectin or mebendazole work against cancer.
No part of the plan has been shown to treat or shrink cancer in a controlled human trial. That includes the vitamins, ivermectin and fasting. The FDA has approved ivermectin only for infections caused by parasites. As a cream or lotion, it is also approved for head lice and rosacea. It has no cancer approval, as we've covered before. A lab theory can sound likely and still not be a treatment. A real treatment has been tested in patients against a placebo or standard care.
What the evidence says
No part of this plan has been shown in a controlled human trial to treat cancer. Lab and animal results often do not hold up in people. The National Cancer Institute says some supplements and other add-on products can change how cancer treatment works. So an untested mix is not a harmless extra.
What to do with this
You may be thinking about an "integrative" cancer plan you saw online. If so, ask two questions first. Has this exact mix been tested in a registered clinical trial? And does the person who recommends it hold an active medical license in good standing? You can check both. Look up trials at ClinicalTrials.gov. Look up licenses through the state or provincial medical board. A plan built on unproven ideas and promoted by an unlicensed co-author is not the same as care backed by evidence. That is true no matter how it is described.
When to talk to your care team
Tell your cancer care team about anything you're thinking of adding to your treatment. That includes vitamins, fasting and older drugs used in new ways. The National Cancer Institute says some of these can change how your cancer treatment works. Your team can help you weigh the risks. You do not need to hide what you are curious about. It is a normal question to ask.
Sources
- Baghli et al., "Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol," Journal of Orthomolecular Medicine, 2024: ISOM
- College of Physicians & Surgeons of Alberta, "Statement: William (Viliam) Makis not licensed to practise medicine in Alberta": cpsa.ca
- Science Feedback, "Lack of evidence for cancer treatment protocol that recommends antiparasitic drugs ivermectin and mebendazole": science.feedback.org
- U.S. Food and Drug Administration, "Ivermectin and COVID-19" (approved uses): fda.gov
- National Library of Medicine catalog, Journal of Orthomolecular Medicine (MEDLINE status): ncbi.nlm.nih.gov
- National Cancer Institute, "Complementary and Alternative Medicine": cancer.gov
- Cancer Explained, "Ivermectin for Cancer: Checking the Claim": /news/claim-check-ivermectin-for-cancer/
How this article was prepared
An AI-assisted editorial system helped prepare this page. It used the published paper, the public statement from Alberta's College of Physicians and Surgeons, and Science Feedback's review. It also used National Cancer Institute guidance. No named medical reviewer has reviewed it unless one is listed.
Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to general. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.
Related Cancer Explained resources
Go deeper with NCI
Watch the short version
Under a minute, captioned, and sourced from federal health agencies.
Pressing play loads the video from YouTube’s privacy-enhanced player (youtube-nocookie.com). Nothing loads from YouTube before then. Educational only, not medical advice.